Home › Funds › GMO › GMO U.S. Equity Fund
Fund family: GMO · Filed by GMO TRUST (CIK 772129) · SEC series S000004081
Share classes and tickers: GMCQX (C000011426), GMEQX (C000011425), GMRTX (C000011424), GMUEX (C000011423)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 1,999 with, 143 against, 0 abstentions (not counted as with management). Shareholder proposals: 40 FOR, 100 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as GMO’s manager page (51,210 ballot items across 26 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | GMO | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 96.3% | 1,966 | 91.3% | 40,970 |
| Backed environmental and social shareholder proposals at US companies | 11.8% | 76 | 10.3% | 369 |
Each ballot item this fund voted is set against the votes of the other GMO funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most GMO funds on all 879 items where a comparison was possible.
The same votes as “with management” above, by the sector of the company voted on. 98.3% of this fund’s 2,142 such votes could be given a sector; the other 37 (1.7%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Consumer Discretionary | 531 | 24 | 4.5% |
| Technology | 379 | 41 | 10.8% |
| Finance | 370 | 25 | 6.8% |
| Industrials | 313 | 18 | 5.8% |
| Consumer Staples | 171 | 13 | 7.6% |
| Health Care | 155 | 10 | 6.5% |
| Energy | 71 | 4 | 5.6% |
| Real Estate | 36 | 0 | 0.0% |
| Telecommunications | 28 | 4 | 14.3% |
| Miscellaneous | 26 | 0 | 0.0% |
| Utilities | 25 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 1,555 | 4 |
| Say-on-Pay | 177 | 0 |
| Audit-related | 164 | 0 |
| Corporate Governance | 85 | 53 |
| Compensation | 66 | 4 |
| Environment or Climate | 35 | 35 |
| Other Social Issues | 28 | 28 |
| Capital Structure | 18 | 0 |
| Human Rights or Human Capital/workforce | 12 | 12 |
| Shareholder Rights and Defenses | 9 | 6 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Apple Inc. | February 24, 2026 | $18M | 12 | 1 |
| NVIDIA Corporation | June 24, 2026 | $14M | 16 | 4 |
| Microsoft Corporation | December 5, 2025 | $12M | 21 | 6 |
| Meta Platforms, Inc. | May 27, 2026 | $9M | 22 | 9 |
| Lam Research Corporation | November 4, 2025 | $7M | 16 | 1 |
| Johnson & Johnson | April 23, 2026 | $7M | 15 | 1 |
| Cisco Systems, Inc. | December 16, 2025 | $6M | 13 | 1 |
| Sandisk Corporation | November 18, 2025 | $6M | 10 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| February 24, 2026 | Apple Inc. | A shareholder proposal entitled "China Entanglement Audit" Shareholder proposal | Against | For |
| June 24, 2026 | NVIDIA Corporation | Approval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposal | For | Against |
| June 24, 2026 | NVIDIA Corporation | Approval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposal | Against | For |
| December 5, 2025 | Microsoft Corporation | European Security Program Censorship Risk Audit Shareholder proposal | Against | For |
| December 5, 2025 | Microsoft Corporation | Report on Risks of Censorship in Generative Artificial Intelligence Shareholder proposal | Against | For |
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding report on Al data usage oversight. Shareholder proposal | Against | For |
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposal | For | Against |
| November 4, 2025 | Lam Research Corporation | Stockholder proposal titled "Realistic Shareholder Ability to Call for a Special Shareholder Meeting," if properly presented. Shareholder proposal | For | Against |
| April 23, 2026 | Johnson & Johnson | Independent Board Chair Shareholder proposal | Against | For |
| December 16, 2025 | Cisco Systems, Inc. | Stockholder Proposal - Approval to request the Board to conduct an evaluation and issue a report assessing how Cisco's Inclusion programs provide positive financial value to shareholders. Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposal | Against | For |
Meetings with a proxy contest or competing nominees (1 in 2025-2026), and how the fund voted the items on its ballot.
2,155 ballot items at 171 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, GMO U.S. Equity Fund (GMCQX) voted at 171 shareholder meetings of 167 companies, on 2,155 ballot items in all. Where management made a recommendation, the fund followed it on 93.3% of the items and voted against it 143 times. Its most frequent area of disagreement was corporate governance (53 of its votes against management). It voted FOR 28.6% of the 140 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than GMO's funds as a whole (96.3% against 91.3%). It voted the same way as most GMO funds on every item where a comparison was possible. 1 of its meetings was contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of GMO’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.